Impact of metformin on gastric adenocarcinoma survival: A Belgian population based study
Background: Preclinical studies have shown anticancer activities of metformin in gastric cancer and a recent epidemiological study showed a decrease in recurrence and mortality of gastric cancer in metformin users. This study aimed to assess the impact of metformin on gastric cancer survival in diabetic patients at a Belgian population level. Methods: We conducted an observational, population-based study by linking data of the Belgian Cancer Registry with medical claims data coming from the health insurance companies for patients diagnosed with stage I to III gastric adenocarcinoma between 200... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2018 |
Verlag/Hrsg.: |
Elsevier
|
Schlagwörter: | Gastric adenocarcinoma / Metformin / Survival / Epidemiology / Pharmacology / Pharmacoepidemiology |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-28879863 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://hdl.handle.net/2078.1/202693 |